Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of the liquid biopsy for the detection of BRAFV600E mutation in metastatic melanoma patients.

Cancer biomarkers : section A of Disease markers - 1 Jan 2019

Salvianti Francesca, Massi Daniela, De Giorgi Vincenzo, Gori Alessia, Pazzagli Mario, Pinzani Pamela

Abstract excerpt

BACKGROUND: Circulating tumor cells (CTCs) and circulating cell free DNA (ccfDNA) represent a liquid biopsy of a tumor allowing real time disease monitoring especially in advanced stages of cancer, but their analysis is technically challenging. OBJECTIVE: We aimed to demonstrate the feasibility of two different technical approaches to detect the BRAFV600E mutation in the liquid biopsy of 20 metastatic melanoma...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Circulating Tumor DNA
Share to Feasibility Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glutamic Acid

Share to Liquid Biopsy

Share to Neoplastic Cells, Circulating

Share to Real-Time Polymerase Chain Reaction

Share to Skin Neoplasms

Share to Valine

Source

Open in PubMed Open full text

Identifiers

PMID: 31524142
DOI: 10.3233/CBM-181647
PMCID: PMC12826423

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of the liquid biopsy for the detection of BRAFV600E mutation in metastatic melanoma patients.PMID 31524142Read ↗

Liquid Biopsy in Melanoma: Significance in Diagnostics, Prediction and Treatment Monitoring.Semantic proximity Read ↗

Liquid biopsy utility for the surveillance of cutaneous malignant melanoma patients.Semantic proximity Read ↗

cfDNA analysis from blood in melanoma.Semantic proximity Read ↗

Comprehensive characterization of circulating tumor cells and cell-free DNA in patients with metastatic melanoma.Semantic proximity Read ↗

Detection of BRAF-V600E and V600K in melanoma circulating tumour cells by droplet digital PCR.Semantic proximity Read ↗

Liquid biopsy-based analysis by ddPCR and CAPP-Seq in melanoma patients.Semantic proximity Read ↗

Isolation of extracellular vesicles improves the detection of mutant DNA from plasma of metastatic melanoma patients.Semantic proximity Read ↗

Analytical reliability of cell-free DNA from fine-needle aspiration rinses for BRAF and NRAS testing in metastatic melanoma.Semantic proximity Read ↗

Efficient treatment of a metastatic melanoma patient with a combination of BRAF and MEK inhibitors based on circulating tumor DNA analysis: a case report.Semantic proximity Read ↗

Detection of Gene Mutations in Liquid Biopsy of Melanoma Patients: Overview and Future Perspectives.Semantic proximity Read ↗

Applicability of liquid biopsies to represent the mutational profile of tumor tissue from different cancer entities.Semantic proximity Read ↗

Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in Melanoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.